Kenji Sakata

Showing 1-2 of 2 articles

Coronary interventions

Complete or incomplete coronary revascularisation in patients with myocardial infarction and multivessel disease: a propensity score analysis from the “real-life” BleeMACS (Bleeding complications in a Multicenter registry of patients discharged with diagnosis of Acute Coronary Syndrome) registry

Quadri G, D’ascenzo F, Moretti C, D’Amico M, Raposeiras-Roubin S, Abu-Assi E, Henriques J, Saucedo J, Gonzalez-Juanatey J, Wilton S, Kikkert W, Nunez-Gil I, Ariza-Sole A, Song X, Alexopoulos D, Liebetrau C, Kawaji T, Huczek Z, Nie S, Fujii T, Correia L, Kawashiri M-a, Garcia-Acuna J, Southern D, Alfonso E, Terol B, Garay A, Zhang D, Chen Y, Xanthopoulou I, Osman N, Möllmann H, Shiomi H, Omedè P, Montefusco A, Giordana F, Scarano S, Kowara M, Filipiak K, Wang X, Yan Y, Fan J-Y, Ikari Y, Nakahayshi T, Sakata K, Yamagishi M, Kalpak O, Kedev S, Varbella F, Gaita F

July 20, 2017 | 10.4244/EIJ-D-16-00350

A Y-shaped bifurcation-dedicated stent for the treatment of de novo coronary bifurcation lesions: an IVUS analysis from the BRANCH trial

Sakata K, Koo B, Waseda K, Nakatani D, Yock P, Whitbourn R, Worthley S, Ormiston J, Webster M, Wilkins G, Honda Y, Meredith I, Fitzgerald P

March 20, 2015 | 10.4244/EIJY14M08_16

1

Latest news

TAVI dysfunction, coronary sinus narrowing, carotid interventions through the snuffbox, and more

CT image showing a case of valve thrombosis after ViV TAVI

February 20, 2020

Will Your Heart Team EXCEL?

February 20, 2020

This Weeks JAA's: SAFE-A study, Coronary access after TAVR-in-TAVR and much more

February 25, 2020

New Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(supported by Biotronik)

February 14, 2020

Guidance Papers

Guidelines, consensus & position papers

New ahead of print: Validation of ARC-HBR criteria

February 18, 2020

New Editor-in-Chief editorial: Moving forward

Davide Capodanno

February 7, 2020

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke